Cited by 29Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Effects of methylphenidate: the cellular point of view

Open access
Bartl, Jasmin, Link, Pille, Schlosser, Corinna, Gerlach, Manfred, Schmitt, Angelika, Walitza, Susanne, Riederer, Peter, Grünblatt, Edna·2010·ADHD Attention Deficit and Hyperactivity Disorders

Abstract

The psychostimulant methylphenidate (MPH) is the first choice of treatment in attention-deficit hyperactivity disorder and is based mainly on inhibition of dopamine transporter (DAT). Nonetheless, the complete cellular effects of MPH are still unknown. We attempted to determine whether MPH influences neurotransmitter levels, synaptic gene expression, and cell proliferation in a dose-dependent manner in rat pheochromocytoma cells (PC12) lacking DAT. PC12 were treated in a dose-dependent manner with MPH. Gene expression level of synaptotagmin (Syt) 1 and 4, syntaxin 1a (Stx1a), and synaptic vesicle glycoprotein 2C (SV2C) was measured using quantitative real-time RT-PCR. Different Neurotransmitter release was measured using high-performance liquid chromatography (HPLC). Differences in cell proliferation were evaluated via BrdU incorporation. Treatment with low-dose MPH (1-100 nM) altered intra-/extracellular neurotransmitter levels, down-regulated all investigated genes as well as enhanced cell proliferation significantly. These data point to diverse effects of MPH on cell metabolism independent of inhibiting DAT.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12402-010-0039-6

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Authors
Bartl, J., Link, P., Schlosser, C., Gerlach, M., Schmitt, A., Walitza, S., Riederer, P., & Grünblatt, E.
Affiliations
  • University of Würzburg (DE)
  • University of Zurich (CH)
Corresponding author
Grünblatt, Edna
Venue
ADHD Attention Deficit and Hyperactivity Disorders
Published
2010-11-10
Volume
2
Issue
4
Pages
225-232
ISSN
  • 1866-6116 (ISSN-L)
  • 1866-6647
OpenAlex
W1965892703
Cited by
29
References
25
Citations by year
2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 4
FWCI
1.31
Type
journal article
Language
en
Open access
Locations
  • ADHD Attention Deficit and Hyperactivity Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • reroDoc Digital Library (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
methylphenidate, dopamine transporter, attention deficit hyperactivity disorder, PC12 cells, synaptotagmin, syntaxin 1A, neurotransmitter release, cell proliferation, synaptic gene expression, psychostimulants, dose-dependent effects
MeSH terms
Central Nervous System Stimulants, Animals, Dose-Response Relationship, Drug, Drug Evaluation, Preclinical, Gene Expression Regulation, Membrane Glycoproteins, Methylphenidate, Nerve Tissue Proteins, Down-Regulation, PC12 Cells, Neurotransmitter Agents, Cell Proliferation, Syntaxin 1, Synaptotagmins, Synaptotagmin I, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review